Evaluation of the impact, treatment patterns, and patient and physician perceptions of vasomotor symptoms associated with menopause in Europe and the United States
Objectives: This study elicited the views of physicians and patients with vasomotor symptoms (VMS) associated with menopause on the impact of VMS and treatment patterns/perceptions. Study design: Data from the Adelphi VMS Disease Specific Programme, a point-in-time survey conducted in 5 European cou...
Main Authors: | Cano, A. (Author), Lee, L. (Author), Schultz, N.M (Author), Scott, M. (Author), Siddiqui, E. (Author), Small, M. (Author), Stute, P. (Author), Thurston, R.C (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier Ireland Ltd
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Comparative study of gabapentin and isoflavone in menopausal vasomotor symptoms
by: Savita Rani Singhal, et al.
Published: (2016-01-01) -
RANKL is a new epigenetic biomarker for the vasomotor symptom during Menopause
by: Kalkan R, et al.
Published: (2020-08-01) -
<i>Rheum rhaponticum</i> Root Extract Improves Vasomotor Menopausal Symptoms and Estrogen-Regulated Targets in Ovariectomized Rat Model
by: Mickey Wilson, et al.
Published: (2021-01-01) -
Vasomotor menopausal symptoms: is it just hot flashes? Alternative non-hormonal methods of treatment with proven effectiveness (literature review)
by: V. N. Kasyan, et al.
Published: (2021-01-01) -
Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene
by: Kagan R, et al.
Published: (2016-04-01)